Enhancement of antiviral cd8+ t-cell responses and complete remission of metastatic melanoma in an hiv-1-infected subject treated with pembrolizumab

HIGHLIGHTS

• who: Oscar Blanch-Lombarte and collaborators from the Infectious Diseases Department, University Hospital "Germans Trias i Pujol", Badalona, Spain have published the research work: Enhancement of Antiviral CD8+ T-Cell Responses and Complete Remission of Metastatic Melanoma in an HIV-1-Infected Subject Treated with Pembrolizumab, in the Journal: (JOURNAL)
• what: The study shows that pembrolizumab treatment resulted in a successful remission of metastatic melanoma in a HIV-1-infected individual, and concomitantly enhanced the HIV-1 specific-CD8+ T-cell response in terms of activation and function.
• how: Data were analyzed with . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.